サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ファーマコビジランス：市場シェア、規模、動向、産業分析レポート-サービス別、製品ライフサイクル別、タイプ別、プロセスフロー別、治療領域別、最終用途別、地域別、セグメント予測（2022～2030年）
市場調査レポート
商品コード
1078387

ファーマコビジランス：市場シェア、規模、動向、産業分析レポート-サービス別、製品ライフサイクル別、タイプ別、プロセスフロー別、治療領域別、最終用途別、地域別、セグメント予測（2022～2030年）

Pharmacovigilance Market Share, Size, Trends, Industry Analysis Report, By Service, By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-Use, By Region; Segment Forecast, 2022 - 2030
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
ファーマコビジランス：市場シェア、規模、動向、産業分析レポート-サービス別、製品ライフサイクル別、タイプ別、プロセスフロー別、治療領域別、最終用途別、地域別、セグメント予測（2022～2030年）
出版日: 2022年04月27日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のファーマコビジランスの市場規模は、2030年までに158億4,000万米ドルに達すると予測されています。

当レポートでは、世界のファーマコビジランス市場について調査分析し、市場力学、ポーターのファイブフォース分析、サービスプロバイダー・製品ライフサイクル・治療領域・プロセスフロー・タイプ・最終用途・地域別市場分析、競合情勢、企業プロファイルに関する情報を提供しています。

目次

第1章 イントロダクション

  • レポートの説明
    • 調査の目的
    • 市場範囲
    • 仮定
  • 利害関係者

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • データソース
    • 一次資料
    • 二次資料

第4章 世界のファーマコビジランス市場の洞察

  • 業界スナップショット
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力（中）
    • 新規参入者の脅威（低）
    • 買い手の交渉力（中）
    • 代替の脅威（中）
    • 既存企業間の競争（高）
  • PESTLE分析
  • ファーマコビジランス業界の動向
  • COVID-19の影響分析

第5章 世界のファーマコビジランス市場：サービスプロバイダー別

  • 主な調査結果
  • イントロダクション
    • サービスプロバイダー別：2018～2030年（10億米ドル）
  • インハウス
    • インハウス別、地域別：2018～2030年（10億米ドル）
  • 契約アウトソーシング
    • 契約アウトソーシング別、地域別：2018～2030年（10億米ドル）

第6章 世界のファーマコビジランス市場：製品ライフサイクル別

  • 主な調査結果
  • イントロダクション
    • 製品ライフサイクル別：2018～2030年（10億米ドル）
  • 前臨床
    • 前臨床別、地域別：2018～2030年（10億米ドル）
  • フェーズI
    • フェーズI別、地域別：2018～2030年（10億米ドル）
  • フェーズII
    • フェーズII別、地域別：2018～2030年（10億米ドル）
  • フェーズIII
    • フェーズIII別、地域別：2018～2030年（10億米ドル）
  • フェーズIV
    • フェーズIV別、地域別：2018～2030年（10億米ドル）

第7章 世界のファーマコビジランス市場：治療領域別

  • 主な調査結果
  • イントロダクション
    • タイプ別：2018～2030年（10億米ドル）
  • 腫瘍学
    • 腫瘍学別、地域別：2018～2030年（10億米ドル）
  • 神経学
    • 神経学、地域別：2018～2030年（10億米ドル）
  • 心臓病学
    • 心臓病学、地域別：2018～2030年（10億米ドル）
  • 呼吸器系
    • 呼吸器系別、地域別：2018～2030年（10億米ドル）
  • その他
    • その他、地域別：2018～2030年（10億米ドル）

第8章 世界のファーマコビジランス市場：プロセスフロー別

  • 主な調査結果
  • イントロダクション
    • プロセスフロー別：2018～2030年（10億米ドル）
  • ケースデータ管理
    • ケースデータ管理別、地域別：2018～2030年（10億米ドル）
    • ケースロギング
    • ケースデータ分析
    • メディカルレビューとレポート
  • 信号検出
    • 信号検出別、地域別：2018～2030年（10億米ドル）
    • 有害事象の記録
    • 有害事象の解析
    • 有害事象レビューとレポート
  • リスク管理システム
    • リスク管理システム別、地域別：2018～2030年（10億米ドル）
    • リスク評価システム
    • リスク軽減システム

第9章 世界のファーマコビジランス市場：タイプ別

  • 主な調査結果
  • イントロダクション
    • タイプ別：2018～2030年（10億米ドル）
  • 自発的報告
    • 自発的報告、地域別：2018～2030年（10億米ドル）
  • ADR報告の強化
    • ADR報告の強化、地域別：2018～2030年（10億米ドル）
  • ターゲットを絞った自発的な報告
    • ターゲットを絞った自発的報告、地域別：2018～2030年（10億米ドル）
  • コホートイベントモニタリング
    • コホートイベントモニタリング、地域別：2018～2030年（10億米ドル）
  • EHRマイニング
    • EHRマイニング、地域別：2018～2030年（10億米ドル）

第10章 世界のファーマコビジランス市場：最終用途別

  • 主な調査結果
  • イントロダクション
    • 最終用途別：2018～2030年（10億米ドル）
  • 医薬品
    • 医薬品別、地域別：2018～2030年（10億米ドル）
  • バイオテクノロジー企業
    • バイオテクノロジー企業別、地域別：2018～2030年（10億米ドル）
  • 医療機器メーカー
    • 医療機器メーカー別、地域別：2018～2030年（10億米ドル）
  • その他
    • その他の最終用途別、地域別：2018～2030年（10億米ドル）

第11章 世界のファーマコビジランス市場： 地域別

  • 主な調査結果
  • イントロダクション
    • 地域別：2018～2030年（10億米ドル）
  • 北米
    • 北米：サービスプロバイダー別-2018～2030年（10億米ドル）
    • 北米：プロセスフロー別-2018～2030年（10億米ドル）
    • 北米：製品ライフサイクル別-2018～2030年（10億米ドル）
    • 北米：タイプ別-2018～2030年（10億米ドル）
    • 北米：治療領域別-2018～2030年（10億米ドル）
    • 北米：最終用途別-2018～2030年（10億米ドル）
    • 米国
    • カナダ
  • 欧州
    • 欧州：サービスプロバイダー別-2018～2030年（10億米ドル）
    • 欧州：プロセスフロー別-2018～2030年（10億米ドル）
    • 欧州：製品ライフサイクル別-2018～2030年（10億米ドル）
    • 欧州：タイプ別-2018～2030年（10億米ドル）
    • 欧州：治療領域別-2018～2030年（10億米ドル）
    • 欧州：最終用途別-2018～2030年（10億米ドル）
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋
    • アジア太平洋：サービスプロバイダー別-2018～2030年（10億米ドル）
    • アジア太平洋：プロセスフロー別-2018～2030年（10億米ドル）
    • アジア太平洋：製品ライフサイクル別-2018～2030年（10億米ドル）
    • アジア太平洋：タイプ別-2018～2030年（10億米ドル）
    • アジア太平洋：治療領域別-2018～2030年（10億米ドル）
    • アジア太平洋：最終用途別-2018～2030年（10億米ドル）
    • 中国
    • インド
    • 日本
    • マレーシア
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東・アフリカ：サービスプロバイダー別-2018～2030年（10億米ドル）
    • 中東・アフリカ：プロセスフロー別-2018～2030年（10億米ドル）
    • 中東・アフリカ：製品ライフサイクル別-2018～2030年（10億米ドル）
    • 中東・アフリカ：タイプ別-2018～2030年（10億米ドル）
    • 中東・アフリカ：治療領域別-2018～2030年（10億米ドル）
    • 中東・アフリカ：最終用途別-2018～2030年（10億米ドル）
    • サウジアラビア
    • UAE
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：サービスプロバイダー別-2018～2030年（10億米ドル）
    • ラテンアメリカ：プロセスフロー別-2018～2030年（10億米ドル）
    • ラテンアメリカ：製品ライフサイクル別-2018～2030年（10億米ドル）
    • ラテンアメリカ：タイプ別-2018～2030年（10億米ドル）
    • ラテンアメリカ：治療領域別-2018～2030年（10億米ドル）
    • ラテンアメリカ：最終用途別-2018～2030年（10億米ドル）
    • メキシコ
    • ブラジル
    • アルゼンチン

第12章 競合情勢

  • 拡大および買収分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/契約/展示会

第13章 企業プロファイル

  • Accenture
  • ArisGlobal
  • BioClinica, Inc
  • Capgemini
  • Clinquest Group B.V. (Linical Americas)
  • Cognizant
  • FMD K&L
  • IBM Corporation
  • ICON Plc.
  • IQVIA
  • ITClinical
  • Laboratory Corporation of America Holdings
  • Linical Accelovance
  • PAREXEL International Corporation
  • TAKE Solutions
  • United BioSource Corporation
  • Wipro Limited
図表

List of Tables

  • Table 1 Global Pharmacovigilance Market, by Service Provider, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Pharmacovigilance Market, by Process Flow, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Pharmacovigilance Market, by Product Life Cycle, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Pharmacovigilance Market, by Type, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Pharmacovigilance Market, by Therapeutic Area, by Region, 2018 - 2030 (USD Billion)
  • Table 6 Global Pharmacovigilance Market, by End-Use, by Region, 2018 - 2030 (USD Billion)
  • Table 7 Pharmacovigilance Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 8 North America: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 9 North America: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 10 North America: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 11 North America: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 12 North America: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 13 North America: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 14 U.S.: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 15 U.S.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 16 U.S.: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 17 U.S.: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 18 U.S.: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 19 U.S.: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 20 Canada: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 21 Canada: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 22 Canada: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 23 Canada: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 24 Canada: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 25 Canada: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 26 Europe: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 27 Europe: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 28 Europe: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 29 Europe: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 30 Europe: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 31 Europe: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 32 UK: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 33 UK: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 34 UK: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 35 UK: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 26 UK: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 37 UK: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 38 France: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 39 France: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 40 France: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 41 France: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 42 France: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 43 France: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 44 Germany: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 45 Germany: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 46 Germany: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 47 Germany: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 48 Germany: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 49 Germany: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 50 Italy: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 51 Italy: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 52 Italy: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 53 Italy: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 54 Italy: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 55 Italy: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 56 Spain: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 57 Spain: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 58 Spain: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 59 Spain: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 60 Spain: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 61 Spain: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 62 Netherlands: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 63 Netherlands: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 64 Netherlands: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 65 Netherlands: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 66 Netherlands: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 67 Netherlands: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 68 Russia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 69 Russia: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 70 Russia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 71 Russia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 72 Russia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 73 Russia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 74 Asia Pacific: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 75 Asia Pacific: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 76 Asia Pacific: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 77 Asia Pacific: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 78 Asia Pacific: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 79 Asia Pacific: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 80 China: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 81 China: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 82 China: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 83 China: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 84 China: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 85 China: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 86 India: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 87 India: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 88 India: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 89 India: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 90 India: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 91 India: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 92 Japan: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 93 Japan: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 94 Japan: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 95 Japan: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 96 Japan: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 97 Japan: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 98 Malaysia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 99 Malaysia: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 100 Malaysia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 101 Malaysia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 102 Malaysia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 103 Malaysia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 104 Indonesia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 105 Indonesia: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 106 Indonesia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 107 Indonesia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 108 Indonesia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 109 Indonesia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 110 South Korea: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 111 South Korea: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 112 South Korea: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 113 South Korea: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 114 South Korea: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 115 South Korea: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 116 Middle East & Africa: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 117 Middle East & Africa: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
目次
Product Code: PM2355

The global pharmacovigilance market size is expected to reach USD 15.84 Billion by 2030 according to a new study by Polaris Market Research. The report "Pharmacovigilance Market Share, Size, Trends, Industry Analysis Report, By Service, By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-Use, By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The primary drivers of the market include rising medication intake novel drug development frequencies, rising prices of negative drug responses and drug toxicities, as well as an expanding tendency of contracting pharmacovigilance solutions is expected to boost the industry growth. Moreover, the pharmaceutical sector's excessive expenditure, rising incidence of adverse drug events, and drug mistakes are propelling the industry forward. Furthermore, the coronavirus pandemic has produced an emergency demand for a vaccine that has offered several chances for industry participants.

The contract outsources segment is expected to hold the major shares in the global market during the forecast period due to its benefits such as transforming fixed supply costs into variables, refining on-demand contact to distinctive expertise along with other benefits.

North America is expected to hold the major share in the global market over the forecast period due to increasing investment by the industry players in introducing novel drugs. Moreover, stringent regulations along with the presence of advanced healthcare systems in countries like the U.S. and Canada are expected to create lucrative opportunities for industry growth.

Some of the major players operating in the global market are ArisGlobal, Accenture, BioClinica, Inc., United BioSource Corporation, Clinquest Group B.V. (Linical Americas), Cognizant, Capgemini, FMD K&L, IBM Corporation, IQVIA, ICON Plc., ITClinical, Linical Accelovance, PAREXEL International Corporation, Laboratory Corporation of America Holdings, TAKE Solutions, and Wipro Limited.

Polaris Market Research has segmented the pharmacovigilance market report on the basis of service provider, product life cycle, type, process flow, therapeutic area, end-use, and region:

Pharmacovigilance, Service Provider Outlook (Revenue - USD Billion, 2018 - 2030)

In-house

Contract Outsourcing

Pharmacovigilance, Product Life Cycle Outlook (Revenue - USD Billion, 2018 - 2030)

Pre-clinical

Phase I

Phase II

Phase III

Phase IV

Pharmacovigilance, Type Outlook (Revenue - USD Billion, 2018 - 2030)

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

Pharmacovigilance, Process Flow Outlook (Revenue - USD Billion, 2018 - 2030)

Case Data Management

Case Logging

Case Data Analysis

Medical Reviewing & Reporting

Signal Detection

Adverse Event Logging

Adverse Event Analysis

Adverse Event Review & Reporting

Risk Management System

Risk Evaluation System

Risk Mitigation System

Pharmacovigilance, Therapeutic Area Outlook (Revenue - USD Billion, 2018 - 2030)

Oncology

Neurology

Cardiology

Respiratory Systems

Others

Pharmacovigilance, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Pharmaceuticals

Biotechnology Companies

Medical Device Manufacturers

Others

Pharmacovigilance, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S.

Canada

Europe

Germany

UK

Italy

France

Netherlands

Russia

Spain

Asia Pacific

China

Japan

India

Indonesia

Malaysia

South Korea

Latin America

Brazil

Argentina

Mexico

Middle East & Africa

Israel

Saudi Arabia

South Africa

UAE

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Pharmacovigilance Market Insights

  • 4.1. Pharmacovigilance - Industry Snapshot
  • 4.2. Pharmacovigilance Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising prevalence of chronic disease
      • 4.2.1.2. Increasing investment in drug development
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Issues related to data management
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Pharmacovigilance Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Pharmacovigilance Market, by Service Provider

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • 5.3. In-house
    • 5.3.1. Global Pharmacovigilance Market, by In-house, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Contract Outsourcing
    • 5.4.1. Global Pharmacovigilance Market, by Contract Outsourcing, by Region, 2018 - 2030 (USD Billion)

6. Global Pharmacovigilance Market, by Product Life Cycle

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • 6.3. Pre-clinical
    • 6.3.1. Global Pharmacovigilance Market, by Pre-clinical, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Phase I
    • 6.4.1. Global Pharmacovigilance Market, by Phase I, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Phase II
    • 6.5.1. Global Pharmacovigilance Market, by Phase II, by Region, 2018 - 2030 (USD Billion)
  • 6.6. Phase III
    • 6.6.1. Global Pharmacovigilance Market, by Phase III, by Region, 2018 - 2030 (USD Billion)
  • 6.7. Phase IV
    • 6.7.1. Global Pharmacovigilance Market, by Phase IV, by Region, 2018 - 2030 (USD Billion)

7. Global Pharmacovigilance Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Global Pharmacovigilance Market, by Oncology, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Neurology
    • 7.4.1. Global Pharmacovigilance Market, by Neurology, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Cardiology
    • 7.5.1. Global Pharmacovigilance Market, by Cardiology, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Respiratory Systems
    • 7.6.1. Global Pharmacovigilance Market, by Respiratory Systems, by Region, 2018 - 2030 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Other Pharmacovigilance Market, by Region, 2018 - 2030 (USD Billion)

8. Global Pharmacovigilance Market, by Process Flow

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • 8.3. Case Data Management
    • 8.3.1. Global Pharmacovigilance Market, by Case Data Management, by Region, 2018 - 2030 (USD Billion)
    • 8.3.2. Case Logging
      • 8.3.2.1. Global Pharmacovigilance Market, by Case Logging, by Region, 2018 - 2030 (USD Billion)
    • 8.3.3. Case Data Analysis
      • 8.3.3.1. Global Pharmacovigilance Market, by Case Data Analysis, by Region, 2018 - 2030 (USD Billion)
    • 8.3.4. Medical Reviewing & Reporting
      • 8.3.4.1. Global Pharmacovigilance Market, by Medical Reviewing & Reporting, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Signal Detection
    • 8.4.1. Global Pharmacovigilance Market, by Signal Detection, by Region, 2018 - 2030 (USD Billion)
    • 8.4.2. Adverse Event Logging
      • 8.4.2.1. Global Pharmacovigilance Market, by Adverse Event Logging, by Region, 2018 - 2030 (USD Billion)
    • 8.4.3. Adverse Event Analysis
      • 8.4.3.1. Global Pharmacovigilance Market, by Adverse Event Analysis, by Region, 2018 - 2030 (USD Billion)
    • 8.4.4. Adverse Event Review & Reporting
      • 8.4.4.1. Global Pharmacovigilance Market, by Adverse Event Review & Reporting, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Risk Management System
    • 8.5.1. Global Pharmacovigilance Market, by Risk Management System, by Region, 2018 - 2030 (USD Billion)
    • 8.5.2. Risk Evaluation System
      • 8.5.2.1. Global Pharmacovigilance Market, by Risk Evaluation System, by Region, 2018 - 2030 (USD Billion)
    • 8.5.3. Risk Mitigation System
      • 8.5.3.1. Global Pharmacovigilance Market, by Risk Mitigation System, by Region, 2018 - 2030 (USD Billion)

9. Global Pharmacovigilance Market, by Type

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • 9.3. Spontaneous Reporting
    • 9.3.1. Global Pharmacovigilance Market, by Spontaneous Reporting, by Region, 2018 - 2030 (USD Billion)
  • 9.4. Intensified ADR Reporting
    • 9.4.1. Global Pharmacovigilance Market, by Intensified ADR Reporting, by Region, 2018 - 2030 (USD Billion)
  • 9.5. Targeted Spontaneous Reporting
    • 9.5.1. Global Pharmacovigilance Market, by Targeted Spontaneous Reporting, by Region, 2018 - 2030 (USD Billion)
  • 9.6. Cohort Event Monitoring
    • 9.6.1. Global Pharmacovigilance Market, by Cohort Event Monitoring, by Region, 2018 - 2030 (USD Billion)
  • 9.7. EHR Mining
    • 9.7.1. Global Pharmacovigilance Market, by EHR Mining, by Region, 2018 - 2030 (USD Billion)

10. Global Pharmacovigilance Market, by End-Use

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 10.3. Pharmaceuticals
    • 10.3.1. Global Pharmacovigilance Market, by Pharmaceuticals, by Region, 2018 - 2030 (USD Billion)
  • 10.4. Biotechnology Companies
    • 10.4.1. Global Pharmacovigilance Market, by Biotechnology Companies, by Region, 2018 - 2030 (USD Billion)
  • 10.5. Medical Device Manufacturers
    • 10.5.1. Global Pharmacovigilance Market, by Medical Device Manufacturers, by Region, 2018 - 2030 (USD Billion)
  • 10.6. Others
    • 10.6.1. Global Other End-Uses Pharmacovigilance Market, by Region, 2018 - 2030 (USD Billion)

11. Global Pharmacovigilance Market, by Geography

  • 11.1. Key findings
  • 11.2. Introduction
    • 11.2.1. Pharmacovigilance Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 11.3. Pharmacovigilance Market - North America
    • 11.3.1. North America: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.3.2. North America: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.3.3. North America: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.3.4. North America: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.3.5. North America: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.3.6. North America: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.3.7. Pharmacovigilance Market - U.S.
      • 11.3.7.1. U.S.: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.3.7.2. U.S.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.3.7.3. U.S.: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.3.7.4. U.S.: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.3.7.5. U.S.: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.3.7.6. U.S.: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.3.8. Pharmacovigilance Market - Canada
      • 11.3.8.1. Canada: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.3.8.2. Canada.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.3.8.3. Canada: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.3.8.4. Canada: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.3.8.5. Canada: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.3.8.6. Canada: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 11.4. Pharmacovigilance Market - Europe
    • 11.4.1. Europe: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.4.2. Europe.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.4.3. Europe: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.4.4. Europe: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.4.5. Europe: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.4.6. Europe: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.7. Pharmacovigilance Market - UK
      • 11.4.7.1. UK: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.7.2. UK.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.7.3. UK: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.7.4. UK: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.7.5. UK: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.7.6. UK: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.8. Pharmacovigilance Market - France
      • 11.4.8.1. France: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.8.2. France.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.8.3. France: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.8.4. France: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.8.5. France: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.8.6. France: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.9. Pharmacovigilance Market - Germany
      • 11.4.9.1. Germany: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.9.2. Germany.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.9.3. Germany: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.9.4. Germany: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.9.5. Germany: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.9.6. Germany: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.10. Pharmacovigilance Market - Italy
      • 11.4.10.1. Italy: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.10.2. Italy.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.10.3. Italy: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.10.4. Italy: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.10.5. Italy: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.10.6. Italy: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.11. Pharmacovigilance Market - Spain
      • 11.4.11.1. Spain: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.11.2. Spain.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.11.3. Spain: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.11.4. Spain: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.11.5. Spain: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.11.6. Spain: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.12. Pharmacovigilance Market - Netherlands
      • 11.4.12.1. Netherlands: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.12.2. Netherlands.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.12.3. Netherlands: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.12.4. Netherlands: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.12.5. Netherlands: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.12.6. Netherlands: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.13. Pharmacovigilance Market - Russia
      • 11.4.13.1. Russia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.13.2. Russia.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.13.3. Russia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.13.4. Russia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.13.5. Russia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.13.6. Russia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 11.5. Pharmacovigilance Market - Asia Pacific
    • 11.5.1. Asia Pacific: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.5.2. Asia Pacific.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.5.3. Asia Pacific: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.5.4. Asia Pacific: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.5.5. Asia Pacific: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.5.6. Asia Pacific: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.7. Pharmacovigilance Market - China
      • 11.5.7.1. China: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.7.2. China.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.7.3. China: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.7.4. China: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.7.5. China: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.7.6. China: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.8. Pharmacovigilance Market - India
      • 11.5.8.1. India: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.8.2. India.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.8.3. India: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.8.4. India: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.8.5. India: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.8.6. India: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.9. Pharmacovigilance Market - Japan
      • 11.5.9.1. Japan: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.9.2. Japan.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.9.3. Japan: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.9.4. Japan: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.9.5. Japan: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.9.6. Japan: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.10. Pharmacovigilance Market - Malaysia
      • 11.5.10.1. Malaysia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.10.2. Malaysia.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.10.3. Malaysia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.10.4. Malaysia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.10.5. Malaysia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.10.6. Malaysia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.11. Pharmacovigilance Market - Indonesia
      • 11.5.11.1. Indonesia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.11.2. Indonesia.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.11.3. Indonesia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.11.4. Indonesia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.11.5. Indonesia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.11.6. Indonesia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.12. Pharmacovigilance Market - South Korea
      • 11.5.12.1. South Korea: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.12.2. South Korea.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.12.3. South Korea: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.12.4. South Korea: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.12.5. South Korea: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.12.6. South Korea: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 11.6. Pharmacovigilance Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.6.2. Middle East & Africa: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.6.3. Middle East & Africa: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.6.4. Middle East & Africa: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.6.5. Middle East & Africa: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.6.6. Middle East & Africa: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.6.7. Pharmacovigilance Market - Saudi Arabia
      • 11.6.7.1. Saudi Arabia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.6.7.2. Saudi Arabia.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.6.7.3. Saudi Arabia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.6.7.4. Saudi Arabia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.6.7.5. Saudi Arabia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.6.7.6. Saudi Arabia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.6.8. Pharmacovigilance Market - UAE
      • 11.6.8.1. UAE: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.6.8.2. UAE.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.6.8.3. UAE: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.6.8.4. UAE: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.6.8.5. UAE: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.6.8.6. UAE: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.6.9. Pharmacovigilance Market - Israel
      • 11.6.9.1. Israel: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.6.9.2. Israel.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.6.9.3. Israel: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.6.9.4. Israel: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.6.9.5. Israel: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.6.9.6. Israel: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.6.10. Pharmacovigilance Market - South Africa
      • 11.6.10.1. South Africa: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.6.10.2. South Africa.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.6.10.3. South Africa: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.6.10.4. South Africa: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.6.10.5. South Africa: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.6.10.6. South Africa: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 11.7. Pharmacovigilance Market - Latin America
    • 11.7.1. Latin America: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.7.2. Latin America.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.7.3. Latin America: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.7.4. Latin America: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.7.5. Latin America: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.7.6. Latin America: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.7.7. Pharmacovigilance Market - Mexico
      • 11.7.7.1. Mexico: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.7.7.2. Mexico.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.7.7.3. Mexico: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.7.7.4. Mexico: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.7.7.5. Mexico: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.7.7.6. Mexico: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.7.8. Pharmacovigilance Market - Brazil
      • 11.7.8.1. Brazil: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.7.8.2. Brazil.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.7.8.3. Brazil: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.7.8.4. Brazil: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.7.8.5. Brazil: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.7.8.6. Brazil: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.7.9. Pharmacovigilance Market - Argentina
      • 11.7.9.1. Argentina: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.7.9.2. Argentina.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.7.9.3. Argentina: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.7.9.4. Argentina: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.7.9.5. Argentina: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.7.9.6. Argentina: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
    • 12.1.2. Acquisitions
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Accenture
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. ArisGlobal
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. BioClinica, Inc
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. Capgemini
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Clinquest Group B.V. (Linical Americas)
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. Cognizant
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. FMD K&L
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. IBM Corporation
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. ICON Plc.
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. IQVIA
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development
  • 13.11. ITClinical
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Benchmarking
    • 13.11.4. Recent Development
  • 13.12. Laboratory Corporation of America Holdings
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Benchmarking
    • 13.12.4. Recent Development
  • 13.13. Linical Accelovance
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Benchmarking
    • 13.13.4. Recent Development
  • 13.14. PAREXEL International Corporation
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Benchmarking
    • 13.14.4. Recent Development
  • 13.15. TAKE Solutions
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Benchmarking
    • 13.15.4. Recent Development
  • 13.16. United BioSource Corporation
    • 13.16.1. Company Overview
    • 13.16.2. Financial Performance
    • 13.16.3. Product Benchmarking
    • 13.16.4. Recent Development
  • 13.17. Wipro Limited
    • 13.17.1. Company Overview
    • 13.17.2. Financial Performance
    • 13.17.3. Product Benchmarking
    • 13.17.4. Recent Development